Vacation Resorts: Art and Travel in Mexico |
Stop Parking Domain Names Develop Your Domain Names |
|||||
University of Miami's Miller School of Medicine and Miami Cardiovascular Innovations Partner to Create Biologically Engineered Stents
Miami, Florida (PRWEB) July 2, 2008 -- Miami Cardiovascular Innovations is pleased to announce an agreement to collaborate in research efforts in the development of biologically engineered medical devices, including coronary stents to overcome late stent thrombosis, pacing leads and other products in the cardiovascular space, with University of Miami's Miller School of Medicine.
The biologically engineered stent -- or BES stent now under development -- for which the company has filed patents and the trademark Progeny, can be implanted via minimally invasive procedure. The agreement will use Miami Cardiovascular's novel stem cell-based stent design and the University of Miami's research laboratories and staff to conduct testing. Miami Cardiovascular's biologically engineered approach to stenting can lead to other procedures that could extend and improve the lives of patients requiring different stents.
"I am delighted to have such a prestigious partner in developing this new, ground-breaking medical device technology," said Frank Avellanet, President & CEO of Miami Cardiovascular. "Our know-how combined with the Miller School of Medicine's expertise will ensure the successful outcome of our collaboration and will allow us to quickly bring this new life-saving device to market."
Miami Cardiovascular is seeking additional investors to continue its research and development for several applications. Among the first devices that we are focusing our development work are the next generation of coronary and peripheral stents. Combined these markets exceed $5 billion in annual sales in the US and abroad.
"This unique opportunity brings The University of Miami and Miami Cardiovascular Innovations together with engineers and scientists to develop clinically useful medical products, including biologically engineered stents. This type of collaboration underscores our commitment to developing new devices and bringing the best new technologies to our patients" said Bart Chernow, M.D., Vice President for Special Programs & Resource Strategy for the University.
About Miami Cardiovascular Innovations Miami Cardiovascular Innovations is an interdisciplinary company that combines clinical medicine, molecular biology and biomedical engineering. The three sciences are combined to develop biologically engineered devices. Typically devices are products made out of plastic, metal or a combination of both materials. But MCI uses a more sophisticated approach where it adds science to devices - in this case using stem cells to attract endothelial cells.
For More Information Contact: Frank Avellanet President & CEO Direct: 305-243-4840 Email: MiamiCardio @ aol.com
# # #
This press release has been reprinted from PRWEB per the terms and conditions of the copyright notice.
|
MORE ARTICLES:
Spring Break Soccer Training and Spanish Language Camp in Puerto Vallarta, Mexico
Dream Destination Wedding in a Puerto Vallarta Villa
Puerto Vallarta Vacation Review
Mendocino Coast Hotel Pacific Mist Inn Whale Watchers Festival Vacation Rental Home Special
Discount Last Minute Puerto Vallarta Packages To The Four Seasons Resort Punta Mita
Casa Velas in Puerto Vallarta, Mexico Receives AAA Four Diamond Award
A Mexico Vacation Special To The Maroma Resort In The Mayan Riviera
Livin' La Vida Loca at Puerto Vallarta, Mexico
Puerto Vallarta: The City of Festivals
Win a Luxury All-Inclusive Mexican Vacation for a Family of Four in Puerto Vallarta, Mexico
California Beach Resorts: Ideal Vacation Rentals for You
In-Suite Spa Treatments Exude Romance in Puerto Vallarta, Mexico
Hawaii Maps and Weather Round out Comprehensive Vacation Rental Site
Iconic Mexican Performers Take Flight In Puerto Vallarta
More Vacations at Puerto Vallarta MX
|
|||||
| Develop Your Domain Names | Site Map | Home | ||||||